Category: Diagnostic Technologies

Diagnostic Technologies

Scientist Develops New Way to Test for COVID-19 Antibodies

A scientist suspected he had covid-19, so he came up with a new more broadly applicable antibody test with potential commercial applications.

Diagnostic Technologies

Enterprise-Wide, Cloud-Based Digital Pathology Software Deployed at NCI

Indica Labs’ software is accessible to hundreds of users who manage millions of digital images and analyze thousands of images daily.

Diagnostic Technologies

FDA Clears First CBC Analyzer Developed for Point-of-Care Settings

The XW-100 automated hematology analyzer from Sysmex America is intended for use in patients 2 years of age and older who require a whole blood cell count and white blood cell differential.

Anatomic Pathology

Genomenon Releases CNV Search to Enhance Genomic Interpretation

The latest Mastermind Genomic Search Engine includes Copy Number Variation search to accelerate diagnosis and genomic interpretation of results.

Digital Pathology

Proscia’s Concentriq Selected for Joint Pathology Center

End-to-end transformation will enable groundbreaking biomedical research, advance precision medicine initiatives, and improve routine diagnosis.

Clinical Chemistry

FDA Clears Stat Profile Prime Plus Analyzer for Point-of-Care Use

Agency clearance will allow healthcare personnel to perform bedside critical care testing, with lab-quality results in as little as 1 minute.

Flow Cytometry

How Flow Cytometry Is Being Adopted in Clinical Labs

Compared to other clinical laboratory specialties such as chemistry, hematology, urinalysis, and coagulation, flow cytometry testing has remained a manual process requiring highly skilled laboratory technologists.

Hematology & Serology

Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients

PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.

Immunoassay

Dried Blood Spot Sampling for Covid-19 Antibody Testing

Relative to serum samples, DBS samples achieved 98% sensitivity and 100% specificity for detecting anti-SARS-CoV-2 S glycoprotein antibodies

Mass Spectrometry

InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers

The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.

Microbiology

Agilent Releases SureSelect XT HS2 RNA Reagent Kit

The SureSelect XT HS2 RNA Reagent Kit features a modular design for a simple and parallel approach for both RNA and DNA samples with clinical NGS.

Molecular Diagnostics

Extraction-Free Direct RT-PCR Test for Covid-19

BioGX’s high-throughput RT-PCR test for covid-19 has been submitted for FDA EUA.

Point-of-Care

FDA EUA for Quidel’s Rapid Antigen “ABC Test” for Influenza A and B and Covid-19

The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.

Urinalysis & Toxicology

Molecules in Urine Could Allow Doctors to Monitor Skin Cancer

Researchers have identified fluorescent molecules in urine that may allow patients with malignant melanoma to painlessly find out if treatment is working.